Jaume Mora

The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort

Naxitamab-related adverse events within and across treatment cycles in patients with relapsed/refractory (R/R) high-risk neuroblastoma.

Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence

Failure of human rhombic lip differentiation underlies medulloblastoma formation

BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma

Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation

Sarcoma classification by DNA methylation profiling

The transcriptional landscape of Shh medulloblastoma

Subgroup and subtype-specific outcomes in adult medulloblastoma

Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup

Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features

EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma

Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations

Heterogeneity within the PF-EPN-B ependymoma subgroup

DNA methylation-based reclassification of olfactory neuroblastoma

A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma

HGG-23. DRUG SCREENING LINKED TO MOLECULAR PROFILING IDENTIFIES NOVEL DEPENDENCIES IN PATIENT-DERIVED PRIMARY CULTURES OF PAEDIATRIC HIGH GRADE GLIOMA AND DIPG

Intertumoral Heterogeneity within Medulloblastoma Subgroups

Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma

The whole-genome landscape of medulloblastoma subtypes

EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis